Is it time to rethink syphilis control?

Clin Infect Dis. 2015 Jan 15;60(2):325-6. doi: 10.1093/cid/ciu813. Epub 2014 Oct 16.

Authors

M A Boyd¹, B Donovan¹, G Prestage¹, M Chen², K Petoumenos¹, R Gray¹, R Guy¹, G B Rogers³, C Bourne⁴, J D Klausner⁵

Affiliations

¹ The Kirby Institute, University of New South Wales, Sydney.
² Melbourne Sexual Health Centre, Carlton, Victoria.
³ South Australian Health and Medical Research Institute, North Terrace.
⁴ Sydney Sexual Health Centre, New South Wales, Australia.
⁵ Division of Infectious Diseases and the Program in Global Health David Geffen School of Medicine and Fielding School of Public Health at University of California, Los Angeles.

PMID: 25323705
DOI: 10.1093/cid/ciu813

No abstract available

Publication types

Letter
Comment

MeSH terms

Anti-HIV Agents / administration & dosage*
Female
HIV Infections / complications*
HIV Infections / transmission*
Humans
Male
Pre-Exposure Prophylaxis / methods*
Syphilis / complications*
Syphilis / transmission*

Substances

Anti-HIV Agents